Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Prescription drug marketing practices

Ausness, R.C., "Will More Aggressive Marketing Practices Lead to Greater Tort Liability for Prescription Drug Manufacturers ," Wake Forest L. Rev., 37, 97-139 (2002). [Pg.330]

The FD C Act has been interpreted by FDA as applying only to the labelling, advertising and marketing of a new drug, not to the practice of medicine as reflected in the physician s prescription of the drug for a particular patient. In a policy first published in 1972 and reiterated many times, the FDA has stated that the physician may, within the practice of medicine, lawfully prescribe an approved drug for... [Pg.593]

See other pages where Prescription drug marketing practices is mentioned: [Pg.629]    [Pg.202]    [Pg.569]    [Pg.577]    [Pg.590]    [Pg.614]    [Pg.628]    [Pg.14]    [Pg.169]    [Pg.248]    [Pg.169]    [Pg.61]    [Pg.7]    [Pg.336]    [Pg.403]    [Pg.514]    [Pg.164]    [Pg.427]    [Pg.440]    [Pg.441]    [Pg.441]    [Pg.64]    [Pg.1780]    [Pg.1445]    [Pg.86]    [Pg.596]    [Pg.741]    [Pg.568]    [Pg.670]    [Pg.671]    [Pg.687]    [Pg.690]    [Pg.2826]    [Pg.118]    [Pg.29]    [Pg.3]    [Pg.1760]    [Pg.40]    [Pg.12]    [Pg.52]    [Pg.327]    [Pg.97]    [Pg.296]    [Pg.79]    [Pg.198]    [Pg.446]    [Pg.69]   
See also in sourсe #XX -- [ Pg.429 , Pg.441 , Pg.442 ]



SEARCH



Drug market

Drug marketability

Marketed drugs

Marketing practices

Marketing prescription drug

© 2024 chempedia.info